The event is the consolidation of human simulation as a commercial scaling law: Simile AI's $2B Series B and the coverage framing it as the moment the 'human subject'—focus groups, user studies, A/B test panels—becomes an inference workload. The new claim is not that agents can pretend to be people, but that post-trained digital twins can stand in for real populations at commercially relevant fidelity.12

Context

Both documents trace the lineage from the 2023 Smallville generative agents paper to simulations of 1,000 people and then to Simile. AINews places this as stage seven of a longer pattern: reward models, synthetic corpora, distillation, self-curricula, automated research, and synthetic environments all flipped from human-made to model-made before the human subject did. What changed is that the remaining bottleneck in this trajectory is no longer generation quality but verification.12

Assessment

The constraint shift is from model capability to data and verification. Simile's differentiator is post-training on interviews, transactions, and registered RCTs to recover human bias, inconsistency, and causal texture that frontier 'agent models' optimize away. The credible version of the claim is that the binding constraint for replacing human subjects is not how realistic the generation looks, but whether the synthetic population can be trusted—hence the emphasis on registered RCTs as a verification mechanism.12

Caveats

The evidence base is thin for the headline numbers. The 85% figure compares digital twins to humans' own two-week test-retest reliability, not to ground truth about future behavior; the '10% worse, 100x cheaper, 10000x faster' trade-off is a slogan without a published methodology. No independent evaluation of Simile's Fortune 100 results is provided. I would revise the assessment if a blinded, preregistered study showed simulated populations predicting consequential decisions—purchases, votes, dropout—better than a random human panel at comparable cost.12